Brief: Omega Diagnostics Sees FY24 To Be A Year Of Significant Revenue Growth And Return To Positive EBITDA
Jan 18 (Reuters) - Omega Diagnostics Group PLC ODX.L :
* OMEGA DIAGNOSTICS GP - TRADING UPDATE
* OMEGA DIAGNOSTICS GROUP PLC - STILL FULLY EXPECT FY24 TO
BE A
YEAR OF SIGNIFICANT REVENUE GROWTH AND A RETURN TO POSITIVE
EBITDA
Source text for Eikon: ID:nRSR0469Na
Further company coverage: ODX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambridge Nutritional Sciences
See all newsBrief: Cambridge Nutrition Says Adj Ebitda Expected To Show Loss Of £0.4 Mln For Year Ended 31 March 2026
UK's Cambridge Nutritional Sciences yearly revenue as geopolitical turmoil delays overseas orders
Cambridge Nutrition. - Trading & Business Update
Cambridge Nutrition. - Holding(s) in Company
Cambridge Nutrition. - Holding(s) in Company